1. Home
  2. HQY vs HALO Comparison

HQY vs HALO Comparison

Compare HQY & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HealthEquity Inc.

HQY

HealthEquity Inc.

HOLD

Current Price

$73.19

Market Cap

7.9B

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$77.44

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HQY
HALO
Founded
2002
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
8.8B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
HQY
HALO
Price
$73.19
$77.44
Analyst Decision
Buy
Buy
Analyst Count
15
12
Target Price
$118.40
$76.42
AVG Volume (30 Days)
1.1M
1.9M
Earning Date
03-17-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
99.97
56.68
EPS
2.18
4.74
Revenue
$1,290,660,000.00
$1,242,852,000.00
Revenue This Year
$10.35
$39.17
Revenue Next Year
$7.55
$26.89
P/E Ratio
$33.65
$16.24
Revenue Growth
12.20
31.19
52 Week Low
$72.99
$47.50
52 Week High
$116.65
$82.22

Technical Indicators

Market Signals
Indicator
HQY
HALO
Relative Strength Index (RSI) 25.52 58.63
Support Level $77.44 $71.23
Resistance Level $80.83 $82.22
Average True Range (ATR) 3.16 2.48
MACD -0.58 0.38
Stochastic Oscillator 1.99 63.43

Price Performance

Historical Comparison
HQY
HALO

About HQY HealthEquity Inc.

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: